FDA Drug Application (020131) for PROHANCE by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number020131
Product Number001
FormINJECTABLE;INJECTION
Dosage279.3MG/ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePROHANCE
Active IngredientGADOTERIDOL

Active IngredientCount
List of drugs with Active Ingredient GADOTERIDOL2


Back to FDA Applications sponsored by BRACCO